Metraipolis › archive › dc_bd5493882929

Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence — Europe PMC PMID:42098370

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42098370
DOI
10.1007/s00330-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-02T16:13:26.641Z
SHA-256 of the archived text
dd17215737b22eda456e5cc6042633dc8625e5b9a3629c0ade462d7a9c017cc1
Stable URL of this page
https://metraipolis.com/documento/dc_bd5493882929

How to cite

Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence — Europe PMC PMID:42098370 — Europe PMC (en), https://europepmc.org/article/MED/42098370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bd5493882929 (Metraipolis archive dc_bd5493882929, sha256 dd17215737b22eda456e5cc6042633dc8625e5b9a3629c0ade462d7a9c017cc1)
BibTeX
@misc{dcbd5493882929,
  title = {Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence — Europe PMC PMID:42098370},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42098370},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bd5493882929; sha256 dd17215737b22eda456e5cc6042633dc8625e5b9a3629c0ade462d7a9c017cc1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42098370. Agents can read the archived copy with the MCP tool read_document.